Director, President and CEO · Century Therapeutics, Inc. · Common Stock
Side
SELL
Value
$15K
Shares
32.5K
Price
$0.45
Executed
Nov 17, 2025
Disclosed
Nov 19, 2025
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Nov 17 executedNov 19, 2025 disclosed
IPSC · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering+10 / 15
2 other actors traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Pfeiffenberger Brent filed this Form 4 reporting a open-market sale of IPSC on Nov 17, 2025. It became public on Nov 19, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Pfeiffenberger Brentcik:0002001162
Issuer
Century Therapeutics, Inc.cik:0001850119
Revision history · 0
No field has changed since this record was first ingested.
